Trapencaine

CAS No. 76629-91-9

Trapencaine( —— )

Catalog No. M36243 CAS No. 76629-91-9

Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 202 Get Quote
5MG 304 Get Quote
10MG 447 Get Quote
25MG 710 Get Quote
50MG 994 Get Quote
100MG 1314 Get Quote
500MG 2628 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Trapencaine
  • Note
    Research use only, not for human use.
  • Brief Description
    Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
  • Description
    Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    76629-91-9
  • Formula Weight
    374.52
  • Molecular Formula
    C22H34N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C(NC1=CC(OCCCCC)=CC=C1)=O)C2C(CCCC2)N3CCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pilsicainide HCl

    Pilsicainide HCl is a pure sodium channel blocker.

  • Vernakalant Hydrochl...

    Vernakalant Hydrochloride (RSD1235 hydrochloride) is a mixed voltage- and frequency-dependent Na+ and atria-preferred K+ channel blocker.

  • VGSCs-IN-1

    VGSCs-IN-1 is a potent VGSC inhibitor, a 2-piperazine analog of Riluzole that exhibits good blocking activity on Nav1.4.VGSCs-IN-1 can be used to study cellular excitability disorders.